Working… Menu
Trial record 1 of 1502 for:    leukine
Previous Study | Return to List | Next Study

Biomarker Assessments of Leukine During Treatment of Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03790670
Recruitment Status : Recruiting
First Posted : January 2, 2019
Last Update Posted : October 19, 2020
Information provided by (Responsible Party):
Howard Gendelman, MD, University of Nebraska

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 30, 2022
Estimated Study Completion Date : December 30, 2022
Publications automatically indexed to this study by Identifier (NCT Number):